Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Validity and reliability of the FSS in Greek MS patients.
Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
A prospective study of "undiagnosed" isolated myelopathy: I. Case selection and clinical features.
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.
Job placement interventions for people with multiple sclerosis.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Explaining, not just predicting, drives interest in personal genomics.
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
Factors Associated with Employment Status in Individuals with Multiple Sclerosis.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Disease mechanisms in MS: Neuronal network connectivity is altered in multiple sclerosis.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Primary progressive multiple sclerosis: progress and challenges.
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.]
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.

Pages